Clinical trials
Phase 1 trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 13 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 13 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 63 |
| Recruiting | 12 |
| Active, not recruiting | 7 |
| Unknown status | 5 |
| Terminated | 4 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bial - Portela C S.A. | 26 |
| Achieve Life Sciences | 4 |
| Boehringer Ingelheim | 4 |
| Daiichi Sankyo | 4 |
| Novartis Pharmaceuticals | 4 |
| Hoffmann-La Roche | 3 |
| Italfarmaco | 3 |
| Universidade do Porto | 3 |
| Amgen | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 15 |
| Epilepsy | 9 |
| Neoplasms | 4 |
| Ovarian Neoplasms | 3 |
| Renal Insufficiency | 3 |
| Antiphospholipid Syndrome | 2 |
| Arthritis, Rheumatoid | 2 |
| Behcet Syndrome | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 76 to 94 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.